Efficacy and safety of atomoxetine hydrochloride in Korean adults with attention-deficit hyperactivity disorder-Reference-Cited by-同舟云学术

Efficacy and safety of atomoxetine hydrochloride in Korean adults with attention-deficit hyperactivity disorder

Published:2014-10-27 Issue:4 Volume:6 Page:386-396
ISSN:1758-5864
Container-title:Asia-Pacific Psychiatry
language:en
Short-container-title:Asia-Pacific Psychiatry

Author:

Lee Soyoung Irene¹,Song Dong-Ho²,Shin Dong Won³,Kim Ji Hoon⁴,Lee Young Sik⁵,Hwang Jun-Won⁶,Park Tae Won⁷,Yook Ki-Hwan⁸,Lee Jong Il⁹,Bahn Geon Ho¹⁰,Hirata Yuko¹¹,Goto Taro¹¹,Takita Yasushi¹¹,Takahashi Michihiro¹¹¹²,Lee Sanghoon¹³,Treuer Tamás¹⁴

Affiliation:

1. Department of Psychiatry, College of Medicine; Soonchunhyang University Bucheon Hospital; Bucheon Republic of Korea

2. Department of Pediatric Psychiatry, Severance Hospital; Yonsei University College of Medicine; Seoul Republic of Korea

3. Department of Psychiatry, Kangbuk Samsung Hospital; Sungkyunkwan University School of Medicine; Seoul Republic of Korea

4. Department of Psychiatry; Pusan National University School of Medicine; Yangsan-si Republic of Korea

5. Department of Neuropsychiatry, College of Medicine; Chung-Ang University Medical Center; Seoul Republic of Korea

6. Department of Neuropsychiatry, Kangwon National University Hospital; Kangwon National University School of Medicine; Chuncheon Republic of Korea

7. Department of Psychiatry; Chonbuk National University Medical School; Jeonju Republic of Korea

8. Department of Psychiatry, Bundang CHA Medical Center; School of Medicine CHA University; Seongnam Republic of Korea

9. Department of Psychiatry; Seoul National Hospital; Seoul Korea

10. Department of Neuropsychiatry; Kyung Hee University School of Medicine; Seoul Republic of Korea

11. Eli Lilly Japan K.K.; Kobe Japan

12. Takahashi Psychiatric Clinic; Ashiya Japan

13. Eli Lilly Korea, Ltd.; Seoul Republic of Korea

14. Neuroscience Research; Eli Lilly and Company; Budapest Hungary

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Psychiatry and Mental health,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/appy.12160/fullpdf

Reference37 articles.

1. Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder;Adler;Psychiatr Clin North Am,2004

2. Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials;Balk;JAMA,2002

3. Less discontinuation of ADHD drug use since the availability of long-acting ADHD medication in children, adolescents and adults under the age of 45 years in the Netherlands;Ban;Atten Defic Hyperact Disord.,2010

4. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder;Barkley;J Abnorm Psychol,2002

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current nonstimulant medications for adults with attention-deficit/hyperactivity disorder;Expert Review of Neurotherapeutics;2024-06-25

2. BRIEF-A: Factor structure and measurement invariance across self-report and informant forms;Applied Neuropsychology: Adult;2023-11-21

3. Do ADHD Treatments Improve Executive Behavior Beyond Core ADHD Symptoms in Adults? Evidence From Systematic Analysis of Clinical Trials;The Journal of Clinical Pharmacology;2023-03-13

4. Adult Patient Preferences for Long-Acting ADHD Treatments: A Discrete Choice Experiment;Patient Preference and Adherence;2021-05

5. Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis;PLOS ONE;2020-10-21